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Abstract    
GADD34 is expressed in ischaemic brain and reverses protein synthesis shutdown.  
Consequently, GADD34 could have neuroprotective potential in stroke. BHK 
medium, a replication deficient HSV viral vector (HSV1716) with no insert or 
containing full-length GADD34, the amino terminal or a conserved portion of the 
gene, was injected into mouse brain prior to stroke. Infarct size was 1.0±0.26, 
1.19±0.36, 1.5±0.36, 1.3±0.36  & 1.1±0.28 mm3, respectively. The increase in infarct 
size with full-length GADD34 was statistically significant (p<0.05).  
Immunohistochemistry confirmed viral protein expression.  Tissue culture studies 
revealed GADD34 gene restored virulence in HSV1716 suggesting HSV virulence, 
rather than increased GADD34, exacerbated ischaemic damage.   
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 Introduction 
 
One of the major mechanisms influencing cell survival following stroke is inhibition 
of protein synthesis which can persist for long periods and may not recover in 
selectively vulnerable cells (Paschen, 2003). This is particularly pertinent for cells 
within potentially salvageable penumbral tissue, which if supported to maintain basic 
cellular processes including restoration of protein synthesis, could survive, limiting 
infarct expansion.  
GADD34, one of five distinct GADD genes, is a cell cycle protein inducible by 
growth arrest and DNA damage (Hollander et al., 1997). GADD34 is upregulated in 
rodent and human ischaemic brain (Imai et al., 2002;White et al., 2004) and is known 
to facilitate reversal of protein synthesis shutdown through the dephosphorylation of 
eukaryotic initiation factor 2 alpha (eIF2α) (Novoa et al.,2001).     Since GADD34 
mRNA levels correlate with cell survival during global ischaemia (Doutheil et al., 
1999) it is possible that GADD34 expression may be increased to counteract protein 
synthesis shutdown during cellular stress, thereby promoting cell survival. 
 
The aims of the current study were to generate HSV viral vectors containing full-
length, or GADD34 gene fragments, to investigate the consequences of increased 
GADD34 expression on ischaemic damage in a mouse stroke model.  The hypothesis 
under test was that increased GADD34 expression would limit infarct size.   
 
Materials & Methods 
Viral Vectors 
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BHK cells were propagated in modified Eagle’s medium with 10% newborn calf 
serum/10% tryptose phosphate broth and supplemented with glutamine and 
streptomycin/ penicillin. 3T6 cells were maintained in Dulbecco’s modified Eagle’s 
medium with 10% newborn calf serum and supplemented with glutamine and 
streptomycin/ penicillin.  
 
The MyD116 sequence was pre-cloned into the pCMV-SPORT 6 plasmid 
(Invitrogen). Full-length, conserved 63 amino acid and amino terminal (full-length 
sequence minus conserved sequence) of MyD116 were PCR amplified including the 
CMV IE promoter and contained appropriate start and stop codons. The conserved 
sequence was amplified by PCR, cloned into the pcDNA 3.1 plasmid to gain a CMV 
IE promoter and excised by restriction digest. All three sequences were cloned into 
the RL1deliresGFP plasmid (provided by Dr P Dunn) which contained an inter-
ribosomal entry site and a green fluorescent protein reporter gene (GFP). The 
RL1IRESGFP plasmid contains flanking sequences from either side of the herpes 
simplex viral gene RL1, which codes for ICP34.5.  
 
Plasmid constructs were linearised, incubated with wild-type virus (HSV17+) 
DNA/calf thymus DNA and the mixture applied to confluent monolayers of BHK 
cells for incubation (370C for 4 hours). The plates were then washed, incubated with 
dimethylsulphoxide (4mins), overlaid with medium and maintained at 370C for 72 
hours. Plaques formed from recombinant virus identified by GFP signal were 
harvested and multiple rounds of plaque purification performed until all plaques were 
fluorescent and pure stocks of recombinant virus were produced. Stocks of each 
recombinant virus were grown and titred. 
 4
 Confluent monolayers of BHK and 3T6 cells were infected with HSV17+, HSV1716 
(replication deficient vector lacking the RL1 gene encoding the virulence protein 
ICP34.5 (Brown et al., 1994)) or one of the recombinant viruses at 0.1 p.f.u. per cell 
and absorbed at 370C for 1 hour. The cells were overlaid with medium for incubation 
periods of 6, 24, 48 or 72 hours at 370C and then scraped from the plate and stored at 
–700C. The cells were thawed and sonicated for 5 mins to disrupt cells and release 
progeny virus. Confluent monolayers of BHK and 3T6 cells were infected with serial 
dilutions of each virus for 45mins and overlaid with methyl cellulose for 72 hours at 
370C.  Finally, cells were Giemsa stained and the plaques counted on analogous 
plates.  
 
Animal Procedures 
Procedures were carried out under licence from the UK Home Office. Male C57BL/6 
mice (22-30g) were anaesthetised with halothane (2-3%) in 70% N2O:30% O2 via a 
face mask and placed in a stereotaxic frame. Body temperature was maintained at 
37°C±0.5°C and sub-cutaneous fluids given post-operatively  to prevent dehydration.     
 
Stereotaxic co-ordinates (2mm lateral, 0.5 mm anterior to bregma, 2mm ventral to 
dura) were used to deliver viral vector (1x106p.f.u in 0.17-0.3ul)  and (24 hours later) 
endothelin-1 (ET-1, 400 pmol, 0.5μl, Alexis Biochemicals, UK) into the striatum at 
0.05μlmin-1.  
Mice were randomly assigned to 5 groups (n=8): Group 1:  BHK Medium (vehicle for 
viral vectors); Group 2:  HSV1716 (replication deficient vector). Group 3: 
HSVGADD34 (HSV1716 containing full-length GADD34 gene); Group 4:  
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HSVGADD34conserved (HSV1716 containing GADD34 conserved sequence); 
Group 5:  HSVGADD34aminoterminal (HSV1716 containing GADD34 amino 
terminal sequence). Groups 1 and 2 served as controls.  The experiment was 
terminated by perfusion fixation (4% paraformaldehyde in PBS) 72hrs later.    
 
Approximately 8 sections collected throughout the lesion were stained with H&E and 
examined by an investigator, blind to treatment allocation, to quantify lesion volume. 
Infarcted tissue was identified microscopically, transcribed onto line diagrams and 
measured by image analysis to generate infarct volume. 
 
Immunohistochemistry: striatal sections were dewaxed, dehydrated and microwaved  
(10 min, 10 mM citric acid, pH 6.0). HSV rabbit polyclonal antibody (DAKO; 1:2000) 
or GADD34 (sc-8327, Santa Cruz; 1:100) incubated overnight at 4°C followed by   a 
biotinylated goat anti-rabbit secondary antibody (1:100; Vector Laboratories) used 
with avidin/biotinylated horseradish peroxidase complex (ABC kit, Vector 
Laboratories) and 3,3'-diaminobenzidine (Vector Laboratories).  GFP monoclonal 
antibody (Clontech, 1:100) was used with a biotinylated goat anti-mouse (1:100; 
Vector Laboratories) secondary antibody.  HSV staining mapped  onto line diagrams 
(Figure 1a).   
 
Statistical analysis 
Infarct volume in viral vector groups was compared to the vehicle group using 
repeated measures ANOVA with a Dunnett’s post hoc test to determine statistical 
significance.  All data are expressed as mean ± SD.  
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Results  
Viral protein expression in vivo 
In vivo HSV antigen was detected in cell bodies within the infarct core and peri-
infarct region in all but the vehicle group, confirming spread throughout the target 
zone (red shading in Figure 1a).   
Increased GADD34 immunoreactivity was present in the peri-infarct region of all 
groups in both the cortex and striatum.  However, ischaemia-induced endogenous 
GADD34 (vehicle group, left hand panel, Figure 1b) could not be differentiated from 
viral vector-derived GADD34.  Therefore, GFP was used to confirm expression of 
new viral proteins. GFP was detected in cell bodies within infarct and peri-infarct 
regions in all recombinant virus groups, but not in the vehicle group, confirming cells 
containing the viral vector had expressed gene products (Figure 1b).   
 
Effect GADD34 on infarct size 
ET-1 causes local vasoconstriction resulting in a small, reproducible striatal infarct, 
extending along the needle tract into external capsule and cortex (Figure 1a).   
 
HSVGADD34 caused a significant increase in infarct volume compared to vehicle 
(1.5±0.36 versus 1.0±0.25mm3, p<0.05).  In contrast, HSV1716, 
HSVGADD34conserved and HSVGADD34aminoterminal (1.19±0.36, 1.3±0.35  & 
1.1±0.28 mm3, respectively) had no significant influence on infarct volume.   
 
The HSVGADD34 group displayed a greater spread of HSV immunostaining 
compared to other groups (Figure 1a) similar to a wild-type HSV17+ phenotype.   
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Additional animals, which did not undergo ischaemia, were subsequently injected 
with HSV17+ or the recombinant vectors to check for viral virulence and evidence of 
associated pathology.  HSV 1716, HSVGADD34conserved and 
HSVGADD34aminoterminal constructs induced a mild inflammatory response 
around the needle tract (Figure 1c, bottom right hand panel) and mice showed no 
signs of ill health. As expected, 72 hours after HSV17+ injection, histology  showed 
evidence of encephalitis characterised by perivascular inflammation, leptomeningeal 
inflammation, neuronophagia and necrotising encephalitis (Figure 1, top left panel).  
A similar pattern of pathology was observed with HSVGADD34 (Figure 1c top right 
& bottom left panels).  HSV17+ and HSVGADD34 injected mice displayed 
behavioural signs of ill health such as hunching, shaking, inactivity and 
hypersensitivity, indicative of a wild-type HSV infection.   
 
Virus replication 
Multicycle growth curves provided a replication profile of the three recombinant 
viruses, wild-type HSV17+ and HSV1716. BHK cells were permissive for HSV17+ 
and HSV1716 and this was also true for the recombinant viruses (data not shown). 
3T6 cells were permissive to HSV17+ but were non-permissive for HSV1716, 
HSVGADD34conserved and HSVGADD34aminoterminal. However, HSVGADD34 
showed efficient growth in 3T6 cells where titres reached similar levels to HSV17+ 
(Figure 2). 
 
Discussion 
One of the most critical events induced by cerebral ischaemia is endoplasmic 
reticulum (ER) stress resulting in protein synthesis shutdown.  The mechanism 
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involves upregulation of PKR-like ER kinase (PERK) resulting in phosphorylation of 
eukaryotic translation initiation factor 2α (eIF2α), inhibition of eIF2B and cessation 
of protein synthesis translation (Paschen et al., 2003).  Although, generalised protein 
synthesis is shutdown, certain proteins are upregulated through open reading frame 
bypass scanning (Kojima et al., 2003).  ATF4, an ER stress-induced protein increased 
following eIF2α phosphorylation, induces several downstream genes including  
GADD34 (Blais et al., 2004) which dephosphorylates eIF2α, restoring protein 
synthesis (Novoa et al., 2001).   
 
We have reported upregulation of GADD34 in neurones and microglia in the peri-
infarct region in rodent focal ischaemia (Imai et al., 2002) and in human brain 
following cardiac arrest (White et al., 2004).    Since upregulation is within peri-
infarct tissue and GADD34 is implicated in DNA repair, ischaemic tolerance and 
restoration of protein synthesis (Garcia et al., 2004; Novoa et al., 2001), GADD34 (or 
specific fragments) levels were increased by viral vector gene transfer to determine its 
influence on ischaemic damage.  
 
HSV1716 successfully delivered and increased protein products of inserted genes 
which was confirmed by GFP immunohistochemistry, since viral GADD34 could not 
be distinguished from ischaemia-induced endogenous GADD34.  
 
Unexpectedly, HSVGADD34 significantly increased infarct volume. The fact that 
HSV immunoreactivity spread further in the HSVGADD34 group (Figure 1a) 
alongside behavioural signs of ill health and growth curve data (Figure 2) suggested 
that the full-length GADD34 gene restored virulence to HSV1716.  
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 Histology from animals which received HSVGADD34, without ischaemia confirmed 
evidence of encephalitis and comparable neuropathology to HSV17+ animals,  both 
groups exhibiting behavioural signs indicative of HSV infection.  In contrast, 
HSV1716, HSVGADD34conserved and HSVGADD34aminoterminal groups 
displayed only a mild inflammatory response around the injection tract with no signs 
of ill health.    
 
HSV1716 lacks the virulence protein ICP34.5 (McKay et al., 1993) which prevents 
protein synthesis shutdown upon viral infection, allowing viral replication to occur 
(Chou & Roizman, 1994).  By binding to protein phosphatase1α (PP1α), the carboxyl 
terminal of ICP34.5 removes phosphate from eIF2α in response to a variety of eIF2α 
kinases, including PKR and PERK (Cheng et al., 2005; He et al., 1997).    The full-
length GADD34 gene appears to compensate for the lack of ICP34.5 and restore 
virulence to HSV1716. Therefore, the increased infarct volume seen with 
HSVGADD34 is most likely due to GADD34 restoring virulence to HSV1716 and 
not to increased tissue levels of GADD34 per se.  To avoid this problem, HSV 
amplicons or adenoviruses could be used as alternative delivery vehicles for GADD34 
or studies conducted in GADD34 knockout mice (Kojima et al. 2003) used to provide 
further insights into the role of GADD34 in stroke. 
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Figure Legends 
Figure 1.   
a. Representative line diagrams of a coronal section from each of the five 
experimental groups showing location of the infarct (grey shading) and the spread of 
HSV immunostaining (red shading). Row 2, right-hand panel HSV immunostaining in 
the striatal peri-infarct region of a mouse injected with HSV1716 carrying full-length 
GADD(scale bar:  50μm). 
b.  Top left, endogenous GADD34 immunostaining in striatal peri-infarct region in a 
mouse injected with BHK Medium. Top right  GFP immunostaining in striatal peri-
infarct region in a mouse injected with HSV1716. Bottom left  GFP immunostaining 
in striatal peri-infarct region of a mouse injected with HSV1716 carrying full-length 
GADD. Bottom right  No evidence of GFP immunostaining in striatal peri-infarct 
region of mouse injected with BHK Medium (scale bars:  50μm).   
c. Haematoxylin and Eosin stained sections. Top left, Photomicrograph of striatum  
from animal injected with  wild-type HSV17+ (106 pfu). Top right and bottom left, 
HSVGADD34 (106 pfu) and bottom right, HSV1716 (106 pfu).  Infiltrating 
lymphocytes can be seen both in the striatum, top right, and in the subarachnoid 
space, bottom left, in mice injected with HSVGADD34 indicating acute HSV 
encephalitis.  Bottom left panel also shows the presence of viral meningitis.  Striatum 
from animal injected with HSV1716, bottom right, shows no evidence of HSV 
encephalitis.  (Scale bars:  50μm). 
 
Figure 2.  Growth curves for full-length GADD34, amino terminal and 63 amino acid 
conserved sequence in RL1iresGFP viruses in 3T6 cells. 17+ refers to wild type HSV 
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virus while 1716 refers to the replication deficient HSV viral vector containing no 
gene insert. 
